DJ Novavax Inc. Stock Underperforms Thursday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Novavax Inc. $(NVAX)$ slid 5.35% to $7.07 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index rising 2.74% to 17,166.04 and the Dow Jones Industrial Average rising 1.23% to 40,093.40.
The stock's fall snapped a three-day winning streak.
Novavax Inc. closed 70.37% short of its 52-week high of $23.86, which the company reached on June 6th.
The stock underperformed when compared to some of its competitors Thursday, as Johnson & Johnson $(JNJ)$ fell 0.29% to $154.93, Pfizer Inc. $(PFE)$ rose 1.74% to $22.78, and Merck & Co. Inc. $(MRK)$ rose 1.40% to $79.84.
Trading volume (6.4 M) eclipsed its 50-day average volume of 5.3 M.
Data source: Dow Jones Market Data, FactSet. Data compiled April 24, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
April 24, 2025 17:27 ET (21:27 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。